Ming J. Chen

Person

West Windsor, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Pharmaceutical compositions comprising (S)-4-(4-(4-(((2-(2,6-dioxop...
- Patent number 12,064,427
- Issue date Aug 20, 2024
- Celgene Corporation
- Anjali Agrawal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions comprising (s)-4-(4-(4- (((2-(2,6-dioxo...
- Patent number 11,779,580
- Issue date Oct 10, 2023
- Celgene Corporation
- Anjali Agrawal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oral dosage forms of cyclopropanecarboxylic acid {2-[(1S)-1-(3-etho...
- Patent number 9,757,355
- Issue date Sep 12, 2017
- Celgene Corporation
- Ming J. Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nanosuspension of a poorly soluble drug via microfluidization process
- Patent number 9,616,019
- Issue date Apr 11, 2017
- Celgene Corporation
- Ming J. Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Controlled release oral dosage forms of poorly soluble drugs and us...
- Patent number 9,532,977
- Issue date Jan 3, 2017
- Celgene Corporation
- Ming J. Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nanosuspension of a poorly soluble drug via microfluidization process
- Patent number 9,023,886
- Issue date May 5, 2015
- Celgene Corporation
- Ming J. Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-4-(4-(4-(((2-(2,6-DIOXOP...
- Publication number 20240358697
- Publication date Oct 31, 2024
- Celgene Corporation
- Anjali Agrawal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-4-(4-(4-(((2-(2,6-DIOXOP...
- Publication number 20240066026
- Publication date Feb 29, 2024
- Celgene Corporation
- Anjali Agrawal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-4-(4-(4-(((2-(2,6-DIOXOP...
- Publication number 20200215061
- Publication date Jul 9, 2020
- Celgene Corporation
- Anjali Agrawal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONTROLLED RELEASE ORAL DOSAGE FORMS OF POORLY SOLUBLE DRUGS AND US...
- Publication number 20160128981
- Publication date May 12, 2016
- Celgene Corporation
- Ming J. Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NANOSUSPENSION OF A POORLY SOLUBLE DRUG VIA MICROFLUIDIZATION PROCESS
- Publication number 20150265534
- Publication date Sep 24, 2015
- Celgene Corporation
- Ming J. Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORAL DOSAGE FORMS OF CYCLOPROPANECARBOXYLIC ACID -AMIDE
- Publication number 20140093561
- Publication date Apr 3, 2014
- Celgene Corporation
- Ming J. Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONTROLLED RELEASE ORAL DOSAGE FORMS OF POORLY SOLUBLE DRUGS AND US...
- Publication number 20140018404
- Publication date Jan 16, 2014
- Celgene Corporation
- Ming J. Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nanosuspension of a Poorly Soluble Drug via Microfluidization Process
- Publication number 20110124702
- Publication date May 26, 2011
- Ming J. CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Ming J. Chen

Person

Patents Grantslast 30 patents

Pharmaceutical compositions comprising (S)-4-(4-(4-(((2-(2,6-dioxop...

Pharmaceutical compositions comprising (s)-4-(4-(4- (((2-(2,6-dioxo...

Oral dosage forms of cyclopropanecarboxylic acid {2-[(1S)-1-(3-etho...

Nanosuspension of a poorly soluble drug via microfluidization process

Controlled release oral dosage forms of poorly soluble drugs and us...

Nanosuspension of a poorly soluble drug via microfluidization process

Patents Applicationslast 30 patents

PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-4-(4-(4-(((2-(2,6-DIOXOP...

PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-4-(4-(4-(((2-(2,6-DIOXOP...

PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-4-(4-(4-(((2-(2,6-DIOXOP...

CONTROLLED RELEASE ORAL DOSAGE FORMS OF POORLY SOLUBLE DRUGS AND US...

NANOSUSPENSION OF A POORLY SOLUBLE DRUG VIA MICROFLUIDIZATION PROCESS

ORAL DOSAGE FORMS OF CYCLOPROPANECARBOXYLIC ACID -AMIDE

CONTROLLED RELEASE ORAL DOSAGE FORMS OF POORLY SOLUBLE DRUGS AND US...

Nanosuspension of a Poorly Soluble Drug via Microfluidization Process